THE STRATEGY OF ANTIMICROBIAL THERAPY OF ACUTE UNCOMPLICATED PYELONEPHRITIS FROM THE POSITION OF ETIOLOGICAL DATA

Abstract:Acute pyelonephritis is one of the common diseases both in outpatient and in the hospital practice. The leading causative agent of this disease is E. coli. Obstructive uropathy, foreign body, vesicoureteral reflux, sexual activity, use of local contraceptives contribute to the upward develo...

Full description

Saved in:
Bibliographic Details
Main Authors: A. D. Kaprin, A. A. Kostin, S. V. Popov
Format: Article
Language:Russian
Published: QUASAR, LLC 2015-10-01
Series:Исследования и практика в медицине
Subjects:
Online Access:https://www.rpmj.ru/rpmj/article/view/84
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832568662146416640
author A. D. Kaprin
A. A. Kostin
S. V. Popov
author_facet A. D. Kaprin
A. A. Kostin
S. V. Popov
author_sort A. D. Kaprin
collection DOAJ
description Abstract:Acute pyelonephritis is one of the common diseases both in outpatient and in the hospital practice. The leading causative agent of this disease is E. coli. Obstructive uropathy, foreign body, vesicoureteral reflux, sexual activity, use of local contraceptives contribute to the upward development of urinary infection. The goals of antimicrobial therapy for acute uncomplicated pyelonephritis are: relief of symptoms, restoration of social activity, prevention of complications and relapse prevention. The choice of an antimicrobial agent in most cases is carried out empirically based on the data on the dominant pathogens and their regional resistance. In acute uncomplicated pyelonephritis duration of antimicrobial therapy should be 7–14 days. The drugs of choice for treatment of acute uncomplicated pyelonephritis non-severe in adults are ciprofloxacin and levofloxacin, ceftibuten and cefixime. Patients with acute uncomplicated pyelonephritis severe emergency hospitalization is shown in urological outpatient and parenteral antimicrobial therapy (carbapenems or protected aminopenicillins combined with or without amikacin) with subsequent conversion to oral drugs and infusion therapy.
format Article
id doaj-art-b846c6f1129a4c539b7788e32d83b26f
institution Kabale University
issn 2410-1893
language Russian
publishDate 2015-10-01
publisher QUASAR, LLC
record_format Article
series Исследования и практика в медицине
spelling doaj-art-b846c6f1129a4c539b7788e32d83b26f2025-02-03T00:57:41ZrusQUASAR, LLCИсследования и практика в медицине2410-18932015-10-0123596310.17709/2409-2231-2015-2-3-59-6357THE STRATEGY OF ANTIMICROBIAL THERAPY OF ACUTE UNCOMPLICATED PYELONEPHRITIS FROM THE POSITION OF ETIOLOGICAL DATAA. D. Kaprin0A. A. Kostin1S. V. Popov2NMRRC (Obninsk, Russian Federation)NMRRC (Obninsk, Russian Federation)NMRRC (Obninsk, Russian Federation)Abstract:Acute pyelonephritis is one of the common diseases both in outpatient and in the hospital practice. The leading causative agent of this disease is E. coli. Obstructive uropathy, foreign body, vesicoureteral reflux, sexual activity, use of local contraceptives contribute to the upward development of urinary infection. The goals of antimicrobial therapy for acute uncomplicated pyelonephritis are: relief of symptoms, restoration of social activity, prevention of complications and relapse prevention. The choice of an antimicrobial agent in most cases is carried out empirically based on the data on the dominant pathogens and their regional resistance. In acute uncomplicated pyelonephritis duration of antimicrobial therapy should be 7–14 days. The drugs of choice for treatment of acute uncomplicated pyelonephritis non-severe in adults are ciprofloxacin and levofloxacin, ceftibuten and cefixime. Patients with acute uncomplicated pyelonephritis severe emergency hospitalization is shown in urological outpatient and parenteral antimicrobial therapy (carbapenems or protected aminopenicillins combined with or without amikacin) with subsequent conversion to oral drugs and infusion therapy.https://www.rpmj.ru/rpmj/article/view/84pyelonephritisescherichia coliurinary tract infectionantimicrobial therapyfluoroquinolonescephalosporinscarbapenems
spellingShingle A. D. Kaprin
A. A. Kostin
S. V. Popov
THE STRATEGY OF ANTIMICROBIAL THERAPY OF ACUTE UNCOMPLICATED PYELONEPHRITIS FROM THE POSITION OF ETIOLOGICAL DATA
Исследования и практика в медицине
pyelonephritis
escherichia coli
urinary tract infection
antimicrobial therapy
fluoroquinolones
cephalosporins
carbapenems
title THE STRATEGY OF ANTIMICROBIAL THERAPY OF ACUTE UNCOMPLICATED PYELONEPHRITIS FROM THE POSITION OF ETIOLOGICAL DATA
title_full THE STRATEGY OF ANTIMICROBIAL THERAPY OF ACUTE UNCOMPLICATED PYELONEPHRITIS FROM THE POSITION OF ETIOLOGICAL DATA
title_fullStr THE STRATEGY OF ANTIMICROBIAL THERAPY OF ACUTE UNCOMPLICATED PYELONEPHRITIS FROM THE POSITION OF ETIOLOGICAL DATA
title_full_unstemmed THE STRATEGY OF ANTIMICROBIAL THERAPY OF ACUTE UNCOMPLICATED PYELONEPHRITIS FROM THE POSITION OF ETIOLOGICAL DATA
title_short THE STRATEGY OF ANTIMICROBIAL THERAPY OF ACUTE UNCOMPLICATED PYELONEPHRITIS FROM THE POSITION OF ETIOLOGICAL DATA
title_sort strategy of antimicrobial therapy of acute uncomplicated pyelonephritis from the position of etiological data
topic pyelonephritis
escherichia coli
urinary tract infection
antimicrobial therapy
fluoroquinolones
cephalosporins
carbapenems
url https://www.rpmj.ru/rpmj/article/view/84
work_keys_str_mv AT adkaprin thestrategyofantimicrobialtherapyofacuteuncomplicatedpyelonephritisfromthepositionofetiologicaldata
AT aakostin thestrategyofantimicrobialtherapyofacuteuncomplicatedpyelonephritisfromthepositionofetiologicaldata
AT svpopov thestrategyofantimicrobialtherapyofacuteuncomplicatedpyelonephritisfromthepositionofetiologicaldata
AT adkaprin strategyofantimicrobialtherapyofacuteuncomplicatedpyelonephritisfromthepositionofetiologicaldata
AT aakostin strategyofantimicrobialtherapyofacuteuncomplicatedpyelonephritisfromthepositionofetiologicaldata
AT svpopov strategyofantimicrobialtherapyofacuteuncomplicatedpyelonephritisfromthepositionofetiologicaldata